LumiraDx Limited (LMDXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
+0.0090 (900.00%)
Inactive · Last trade price
on Oct 25, 2024
LumiraDx Market Cap
LumiraDx has a market cap or net worth of $3.59 million as of December 27, 2024. Its market cap has decreased by -96.64% in one year.
Market Cap
3.59M
Enterprise Value
438.65M
Revenue
126.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 19, 2021, LumiraDx's market cap has decreased from 122.50M to 3.59M, a decrease of -97.07%. That is a compound annual growth rate of -62.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 25, 2024 | 3.59M | -82.12% |
| Dec 29, 2023 | 20.07M | -92.98% |
| Dec 30, 2022 | 285.92M | -87.30% |
| Dec 31, 2021 | 2.25B | 1,738.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 19.03B |
| Telix Pharmaceuticals Limited | 4.64B |
| Elekta AB (publ) | 2.48B |
| Ryman Healthcare Limited | 2.06B |
| Verano Holdings Corp. | 1.28B |
| Vireo Growth Inc. | 104.57M |
| Medexus Pharmaceuticals Inc. | 45.49M |